Literature DB >> 12406554

Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer.

Joanne E Curran1, Stephen R Weinstein, Lyn R Griffiths.   

Abstract

Nuclear factor kappa-beta (NF-kappaB) is a transcription factor responsible for modulating the expression of many genes involved in cell proliferation, differentiation, apoptosis and metastasis. NF-kappaB interacts with IkappaB inhibitory proteins to regulate gene expression. This study investigated common variants within the genes coding for NF-kappaB and IkappaB, NFKB1 and NFKBIA, for involvement in sporadic breast cancer. Genotypes were determined in a population of breast cancer affected individuals and age-matched controls. Results do not support an involvement of the tested NFKB1 and NFKBIA polymorphisms in susceptibility to sporadic breast cancer, in the tested Caucasian population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406554     DOI: 10.1016/s0304-3835(02)00460-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  30 in total

1.  Identification of autophagy signaling network that contributes to stroke in the ischemic rodent brain via gene expression.

Authors:  Kun Liang; Lei Zhu; Jinyun Tan; Weihao Shi; Qing He; Bo Yu
Journal:  Neurosci Bull       Date:  2015-08-08       Impact factor: 5.203

2.  NFKB1 -94ins/del ATTG polymorphism increases osteosarcoma risk in a Chinese Han population.

Authors:  Xiyi Li; Chenglin Zhang; Wei Qiao; Xuhui Zhou; Menghong Sun
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Association of Genetic Variants in NF-kB with Susceptibility to Breast Cancer: a Case Control Study.

Authors:  Rabeb M Ghali; Sana Mahjoub; Sonia Zaied; Hanen Bhiri; Wael Bahia; Touhami Mahjoub; Wassim Y Almawi
Journal:  Pathol Oncol Res       Date:  2018-07-19       Impact factor: 3.201

4.  Risk of meningioma and common variation in genes related to innate immunity.

Authors:  Preetha Rajaraman; Alina V Brenner; Gila Neta; Ruth Pfeiffer; Sophia S Wang; Meredith Yeager; Gilles Thomas; Howard A Fine; Martha S Linet; Nathaniel Rothman; Stephen J Chanock; Peter D Inskip
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-04-20       Impact factor: 4.254

5.  Genetic polymorphisms of NFκB1-94ins/delATTG and NFκBIA-881A/G genes in Egyptian patients with colorectal cancer.

Authors:  Mohamed Ragab Youssef; Zeinab Ibraheim Attia; Rizk Ahmed El-Baz; Sameh Roshdy; Ahmad Settin
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

6.  Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients.

Authors:  Huajie Bu; Inger Rosdahl; Xiao-Feng Sun; Hong Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-11       Impact factor: 4.553

Review 7.  Cytokine polymorphism and its possible impact on cancer.

Authors:  Ping Jin; Monica C Panelli; Francesco M Marincola; Ena Wang
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

8.  Association between NF-κBI and NF-κBIA polymorphisms and coronary artery disease.

Authors:  Serdal Arslan; Özge Korkmaz; Nil Özbilüm; Öcal Berkan
Journal:  Biomed Rep       Date:  2015-07-29

9.  Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population.

Authors:  Martha L Slattery; Esther M John; Gabriela Torres-Mejia; Abbie Lundgreen; Jennifer S Herrick; Kathy B Baumgartner; Lisa M Hines; Mariana C Stern; Roger K Wolff
Journal:  Carcinogenesis       Date:  2012-05-04       Impact factor: 4.944

10.  IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.

Authors:  Yongchao He; Hongwei Zhang; Jianhua Yin; Jiaxin Xie; Xiaojie Tan; Shijian Liu; Qian Zhang; Chengzhong Li; Jun Zhao; Hongyang Wang; Guangwen Cao
Journal:  Carcinogenesis       Date:  2009-10-01       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.